ArticlePloS one2024
Hybrid whale algorithm with evolutionary strategies and filtering for high-dimensional optimization: Application to microarray cancer data.
Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The standard whale algorithm is prone to suboptimal results and inefficiencies in high-dimensional search spaces. Therefore, examining the whale optimization algorithm components is critical. The computer-generated initial populations often exhibit an uneven distribution in the solution space, leading to low diversity. We propose a fusion of this algorithm with a discrete recombinant evolutionary strategy to enhance initialization diversity. We conduct simulation experiments and compare the proposed algorithm with the original WOA on thirteen benchmark test functions. Simulation experiments on unimodal or multimodal benchmarks verified the better performance of the proposed RESHWOA, such as accuracy, minimum mean, and low standard deviation rate. Furthermore, we performed two data reduction techniques, Bhattacharya distance and signal-to-noise ratio. Support Vector Machine (SVM) excels in dealing with high-dimensional datasets and numerical features. When users optimize the parameters, they can significantly improve the SVM's performance, even though it already works well with its default settings. We applied RESHWOA and WOA methods on six microarray cancer datasets to optimize the SVM parameters. The exhaustive examination and detailed results demonstrate that the new structure has addressed WOA's main shortcomings. We conclude that the proposed RESHWOA performed significantly better than the WOA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.